Lumos Secures Manufacturing Agreement and Initial US$250,000 Order with Micro-Pak
Lumos Diagnostics Holdings Limited (ASX: LDX) has reported the execution of a contract manufacturing agreement with Micro-Pak®, marking a strategic expansion of its commercial services division. The agreement covers the production of Micro-Pak’s Mold Analyzer system, a point-of-care solution designed for rapid on-site mold detection across professional and consumer applications, offering faster turnaround compared to traditional laboratory testing. The system, developed by Lumos, integrates a proprietary mold detection test, a digital camera reader and a customised mobile application. As part of the agreement, Lumos has received its first purchase order valued at US$250,000, providing early revenue visibility under the three-year contract. The partnership reflects continued demand for Lumos’ diagnostic platform and manufacturing capabilities, supporting growth in its commercial services segment. The agreement also positions the Company to scale production of customised diagnostic solutions and expands its presence in applied testing markets.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Lumos Secures Manufacturing Agreement and Initial US$250,000 Order with Micro-Pak
Lumos Diagnostics Holdings Limited (ASX: LDX) has reported the execution of a contract manufacturing agreement with Micro-Pak®, marking a strategic expansion of its commercial services division. The agreement covers the production of Micro-Pak’s Mold Analyzer system, a point-of-care solution designed for rapid on-site mold detection across professional and consumer applications, offering faster turnaround compared to traditional laboratory testing. The system, developed by Lumos, integrates a proprietary mold detection test, a digital camera reader and a customised mobile application. As part of the agreement, Lumos has received its first purchase order valued at US$250,000, providing early revenue visibility under the three-year contract. The partnership reflects continued demand for Lumos’ diagnostic platform and manufacturing capabilities, supporting growth in its commercial services segment. The agreement also positions the Company to scale production of customised diagnostic solutions and expands its presence in applied testing markets.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au